PlainRecalls
FDA Drug Critical Class I Terminated

Digoxin Tablets, USP 0.125mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC# 10135-0747-01

Reported: September 13, 2023 Initiated: August 25, 2023 #D-1169-2023

Product Description

Digoxin Tablets, USP 0.125mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC# 10135-0747-01

Reason for Recall

Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.

Details

Units Affected
94/100 count bottles
Distribution
Nationwide in the US.
Location
New Castle, DE

Frequently Asked Questions

What product was recalled?
Digoxin Tablets, USP 0.125mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC# 10135-0747-01. Recalled by Marlex Pharmaceuticals, Inc.. Units affected: 94/100 count bottles.
Why was this product recalled?
Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 13, 2023. Severity: Critical. Recall number: D-1169-2023.